Hosted on MSN

Prader-Willi syndrome: A rare disease that causes insatiable hunger

Affected populations: This genetic, multisystem disorder affects an estimated 1 in 30,000 to 1 in 10,000 people worldwide. Most cases of the syndrome occur sporadically, meaning the genetic changes ...
WebMD

Reducing Excessive Hunger in Prader-Willi Syndrome

How Does It Work for Excessive Hunger? Prader-Willi syndrome is a rare condition usually caused by genetic changes in your DNA. It can also occur after a head or brain injury. The condition affects ...
AOL

US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome

(Reuters) -The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic disorder, making it the first treatment available for patients who experience ...
Disability Scoop

FDA Green-Lights First Treatment For Prader-Willi Syndrome

Federal regulators are clearing a first-of-its-kind treatment for symptoms of a rare neurodevelopmental disorder that is characterized by insatiable hunger. The Food and Drug Administration approved a ...
Hosted on MSN

SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug

Shares of Soleno Therapeutics SLNO have rallied 37% in the premarket hours today following the FDA approval of Vykat XR (diazoxide choline) extended-release tablets for treating hyperphagia in adults ...
Benzinga.com

Acadia Pharma Faces Trial Setback As Prader-Willi Syndrome Trial Falls Short

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) released topline results on Wednesday from its Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin (ACP-101) in patients ...
Reuters

US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome

FDA approves first treatment to treat insatiable hunger Vykat XR to be available in US from April 2025 — Soleno March 26 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Soleno ...